We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GENI icon
3051
Genius Sports
GENI
$2.33B
$19K ﹤0.01%
3,320
+3,316
+82,900% +$21.3K
UFPT icon
3052
UFP Technologies
UFPT
$2.49B
$18.9K ﹤0.01%
75
-477
-86% -$90.7K
CSR
3053
Centerspace
CSR
$938M
$18.9K ﹤0.01%
331
-4,836
-94% -$269K
ADEA icon
3054
Adeia
ADEA
$3.29B
$18.8K ﹤0.01%
1,726
-16,455
-91% -$192K
FCOM icon
3055
Fidelity MSCI Communication Services Index ETF
FCOM
$1.8B
$18.8K ﹤0.01%
380
-2,610
-87% -$124K
FG icon
3056
F&G Annuities & Life
FG
$3.59B
$18.8K ﹤0.01%
463
-2,928
-86% -$122K
OMGA
3057
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$18.7K ﹤0.01%
5,135
+1,086
+27% +$4.16K
RPTX
3058
DELISTED
Repare Therapeutics
RPTX
$18.7K ﹤0.01%
3,976
+3,776
+1,888% +$24.2K
OBK icon
3059
Origin Bancorp
OBK
$1.68B
$18.7K ﹤0.01%
599
-9,393
-94% -$291K
GBIO
3060
DELISTED
Generation Bio
GBIO
$18.7K ﹤0.01%
458
-414
-47% -$9.75K
LNZA icon
3061
LanzaTech
LNZA
$70.3M
$18.6K ﹤0.01%
60
+23
+62% +$8.54K
AMC icon
3062
AMC Entertainment Holdings
AMC
$2.23B
$18.6K ﹤0.01%
5,002
-4,943
-50% -$22K
EGRX
3063
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$18.6K ﹤0.01%
3,548
-3,293
-48% -$18.1K
EUFN icon
3064
iShares MSCI Europe Financials ETF
EUFN
$4.31B
$18.6K ﹤0.01%
+817
New +$17.3K
VSTM icon
3065
Verastem
VSTM
$596M
$18.6K ﹤0.01%
1,573
+1,373
+687% +$15.9K
SRI icon
3066
Stoneridge
SRI
$205M
$18.6K ﹤0.01%
1,006
-14,966
-94% -$266K
DERM icon
3067
Journey Medical
DERM
$185M
$18.5K ﹤0.01%
+5,038
New +$21.9K
UNIT
3068
Uniti Group
UNIT
$2.43B
$18.5K ﹤0.01%
3,139
-61,360
-95% -$351K
GROV icon
3069
Grove Collaborative
GROV
$44M
$18.5K ﹤0.01%
11,084
+5,931
+115% +$10.9K
IONQ icon
3070
IonQ
IONQ
$18.7B
$18.5K ﹤0.01%
1,852
-23,875
-93% -$255K
TK icon
3071
Teekay
TK
$1.09B
$18.5K ﹤0.01%
2,537
-15,375
-86% -$120K
GAIN icon
3072
Gladstone Investment Corp
GAIN
$649M
$18.4K ﹤0.01%
1,294
+632
+95% +$8.97K
BCRX icon
3073
BioCryst Pharmaceuticals
BCRX
$2.49B
$18.4K ﹤0.01%
3,621
-6,799
-65% -$38.2K
ATNM icon
3074
Actinium Pharmaceuticals
ATNM
$32.6M
$18.4K ﹤0.01%
2,348
+250
+12% +$1.61K
OLMA icon
3075
Olema Pharmaceuticals
OLMA
$930M
$18.3K ﹤0.01%
1,616
-8,906
-85% -$115K

Similar funds

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.